Sofinnova Investments, Inc.
Filing Date
Global Rank
#1,114
/ 8,603
▲ 72
· as of Mar 2026
Top Industry
Biotechnology
56.8%
3Y Alpha vs SPY
+8.7%
Period ended 3 months ago
Filed May 15, 2026 · 55d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+122.8%
SPY
+76.5%
Annualised alpha
+9.7%
Max drawdown
−37.1%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
65 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
13.7%
−3.5 pts
Top 5
35.3%
−4.2 pts
Top 10
53.3%
−3.4 pts
HHI
446
Diversified−114
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 96.2% | $2,176,311,163 |
| Unclassified | 3.8% | $86,577,000 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
24 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | +3,412,588 | 3,495,888 | $73,238,853 | |
| BMY | Bristol Myers Squibb Co | +475,727 | 1,988,721 | $120,615,928 | |
| SUPN | Supernus Pharmaceuticals, Inc. | +401,214 | 954,309 | $49,328,232 | |
| AXSM | Axsome Therapeutics, Inc. | +400,481 | 412,747 | $69,762,497 | |
| ALC | Alcon Inc | +397,452 | 729,972 | $55,003,390 | |
| CELC | Celcuity Inc. | +366,758 | 666,175 | $76,037,214 | |
| IDYA | IDEAYA Biosciences, Inc. | +246,665 | 1,131,786 | $37,711,109 | |
| XENE | Xenon Pharmaceuticals Inc. | +245,316 | 305,216 | $17,748,310 | |
| IMTX | Immatics N.V. | +194,912 | 3,630,454 | $35,723,667 | |
| INSM | INSMED Inc | +189,274 | 346,075 | $56,590,184 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | +178,702 | 450,096 | $39,144,849 | |
| COGT | Cogent Biosciences, Inc. | +139,926 | 2,113,551 | $81,350,577 | |
| BMRN | Biomarin Pharmaceutical Inc | +84,849 | 781,982 | $44,174,163 | |
| IMNM | Immunome Inc. | +83,427 | 1,701,904 | $37,220,640 | |
| UTHR | UNITED THERAPEUTICS Corp | +82,729 | 240,370 | $142,534,602 | |
| PHVS | Pharvaris N.V. | +73,159 | 818,328 | $23,117,766 | |
| NKTR | Nektar Therapeutics | +70,916 | 509,546 | $36,661,834 | |
| SVRA | Savara Inc | +59,993 | 364,763 | $1,991,605 | |
| WVE | Wave Life Sciences Ltd. | +31,071 | 189,253 | $1,372,084 | |
| DXCM | Dexcom Inc | +15,357 | 393,576 | $24,716,572 | |
| ACAD | Acadia Pharmaceuticals Inc | +12,984 | 78,551 | $1,748,545 | |
| ESTA | Establishment Labs Holdings Inc. | +5,564 | 33,930 | $1,926,545 | |
| MIRM | Mirum Pharmaceuticals, Inc. | +4,491 | 27,591 | $2,548,856 | |
| SLNO | Soleno Therapeutics Inc | +2,275 | 14,689 | $491,787 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
11 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CMPX | Compass Therapeutics, Inc. | −809,285 | 2,556,161 | $13,522,091 | |
| DYN | Dyne Therapeutics, Inc. | −620,264 | 1,633,897 | $29,622,552 | |
| JAZZ | Jazz Pharmaceuticals plc | −361,533 | 598,327 | $113,113,719 | |
| BBIO | BridgeBio Pharma, Inc. | −311,265 | 409,183 | $30,385,929 | |
| ROIV | Roivant Sciences Ltd. | −256,587 | 477,995 | $13,240,461 | |
| RCUS | Arcus Biosciences, Inc. | −173,619 | 923,086 | $19,938,657 | |
| PRAX | Praxis Precision Medicines, Inc. | −62,042 | 63,680 | $20,517,059 | |
| EWTX | Edgewise Therapeutics, Inc. | −51,321 | 386,498 | $12,174,687 | |
| INBX | Inhibrx Biosciences, Inc. | −48,628 | 406,029 | $27,297,329 | |
| ANAB | Anaptysbio, Inc | −39,437 | 248,253 | $9,178,732 | |
| IRON | Disc Medicine, Inc. | −32,690 | 78,320 | $5,007,780 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
22 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AZN | Astrazeneca PLC | 456,031 | $89,938,433 | |
| QQQ | Invesco Qqq Trust, Series 1 | 150,000 | $86,577,000 | |
| BIIB | Biogen Inc. | 229,521 | $42,078,084 | |
| PFE | Pfizer Inc | 800,000 | $22,464,000 | |
| GMAB | Genmab A/S | 752,261 | $20,183,162 | |
| LQDA | Liquidia Corp | 500,000 | $18,870,000 | |
| SYK | Stryker Corp | 44,480 | $14,615,683 | |
| EXEL | Exelixis, Inc. | 251,500 | $10,786,835 | |
| ORIC | Oric Pharmaceuticals, Inc. | 679,578 | $8,610,253 | |
| TNGX | Tango Therapeutics, Inc. | 395,081 | $8,265,094 | |
| TYRA | Tyra Biosciences, Inc. | 204,015 | $7,813,774 | |
| REPL | Replimune Group, Inc. | 1,015,400 | $7,767,810 | |
| AXGN | Axogen, Inc. | 210,665 | $6,979,331 | |
| DFTX | Definium Therapeutics, Inc. | 344,166 | $6,504,737 | |
| CYTK | Cytokinetics Inc | 91,791 | $6,049,944 | |
| MANE | Veradermics, Inc | 73,315 | $4,629,842 | |
| HRMY | Harmony Biosciences Holdings, Inc. | 152,695 | $4,276,986 | |
| PCVX | Vaxcyte, Inc. | 50,600 | $2,940,366 | |
| TENX | Tenax Therapeutics, Inc. | 104,400 | $1,669,356 | |
| SEPN | Septerna, Inc. | 47,506 | $1,141,569 | |
| OKUR | OnKure Therapeutics, Inc. | 141,700 | $586,638 | |
| ZYME | Zymeworks Inc. | 1,610 | $40,314 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
13 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc / Ma | 164,594 | $74,620,335 | |
| ABBV | AbbVie Inc. | 317,783 | $72,610,237 | |
| ISRG | Intuitive Surgical Inc | 126,968 | $71,909,596 | |
| LLY | ELI LILLY & Co | 61,652 | $66,256,177 | |
| APGE | Apogee Therapeutics, Inc. | 534,845 | $40,370,100 | |
| GKOS | GLAUKOS Corp | 288,128 | $32,532,532 | |
| CNTA | Centessa Pharmaceuticals plc | 1,104,274 | $27,617,892 | |
| GEHC | GE HealthCare Technologies Inc. | 160,876 | $13,195,049 | |
| EXAS | EXACT SCIENCES CORP | 101,443 | $10,302,551 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | 527,099 | $6,367,355 | |
| MASI | Masimo Corp | 46,201 | $6,008,902 | |
| QURE | uniQure N.V. | 176,513 | $4,223,956 | |
| EVMN | Evommune, Inc. | 153,320 | $2,624,838 | |
| No positions match the current search. | ||||
65 positions ·
$2,262,888,163 total
· as of Mar 31, 2026
Showing 1–50
of 65 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| NTRA |
Natera, Inc.
Healthcare
|
Held | 1,550,280 | $310,040,497 | 13.70% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Added | 240,370 | $142,534,602 | 6.30% | |
| BMY |
Bristol Myers Squibb Co
Healthcare
|
Added | 1,988,721 | $120,615,928 | 5.33% | |
| JAZZ |
Jazz Pharmaceuticals plc
Healthcare
|
Reduced | 598,327 | $113,113,719 | 5.00% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Held | 2,793,987 | $112,402,097 | 4.97% | |
| AZN |
Astrazeneca PLC
Healthcare
|
NEW | 456,031 | $89,938,433 | 3.97% | |
| QQQ |
Invesco Qqq Trust, Series 1
|
NEW | 150,000 | $86,577,000 | 3.83% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Added | 2,113,551 | $81,350,577 | 3.59% | |
| CELC |
Celcuity Inc.
Healthcare
|
Added | 666,175 | $76,037,214 | 3.36% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Added | 3,495,888 | $73,238,853 | 3.24% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Added | 412,747 | $69,762,497 | 3.08% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
Held | 1,904,408 | $59,588,926 | 2.63% | |
| INSM |
INSMED Inc
Healthcare
|
Added | 346,075 | $56,590,184 | 2.50% | |
| ALC |
Alcon Inc
Healthcare
|
Added | 729,972 | $55,003,390 | 2.43% | |
| SUPN |
Supernus Pharmaceuticals, Inc.
Healthcare
|
Added | 954,309 | $49,328,232 | 2.18% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Added | 781,982 | $44,174,163 | 1.95% | |
| BIIB |
Biogen Inc.
Healthcare
|
NEW | 229,521 | $42,078,084 | 1.86% | |
| BIOA |
BioAge Labs, Inc.
Healthcare
|
Held | 2,293,788 | $40,118,352 | 1.77% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Added | 450,096 | $39,144,849 | 1.73% | |
| AVBP |
ArriVent BioPharma, Inc.
Healthcare
|
Held | 1,696,752 | $39,144,068 | 1.73% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Added | 1,131,786 | $37,711,109 | 1.67% | |
| IMNM |
Immunome Inc.
Healthcare
|
Added | 1,701,904 | $37,220,640 | 1.64% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
Added | 509,546 | $36,661,834 | 1.62% | |
| IMTX |
Immatics N.V.
Healthcare
|
Added | 3,630,454 | $35,723,667 | 1.58% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Reduced | 409,183 | $30,385,929 | 1.34% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Reduced | 1,633,897 | $29,622,552 | 1.31% | |
| INBX |
Inhibrx Biosciences, Inc.
Healthcare
|
Reduced | 406,029 | $27,297,329 | 1.21% | |
| DXCM |
Dexcom Inc
Healthcare
|
Added | 393,576 | $24,716,572 | 1.09% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Added | 818,328 | $23,117,766 | 1.02% | |
| PFE |
Pfizer Inc
Healthcare
|
NEW | 800,000 | $22,464,000 | 0.99% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Reduced | 63,680 | $20,517,059 | 0.91% | |
| GMAB |
Genmab A/S
Healthcare
|
NEW | 752,261 | $20,183,162 | 0.89% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
Reduced | 923,086 | $19,938,657 | 0.88% | |
| LQDA |
Liquidia Corp
Healthcare
|
NEW | 500,000 | $18,870,000 | 0.83% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Added | 305,216 | $17,748,310 | 0.78% | |
| SYK |
Stryker Corp
Healthcare
|
NEW | 44,480 | $14,615,683 | 0.65% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Reduced | 2,556,161 | $13,522,091 | 0.60% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Reduced | 477,995 | $13,240,461 | 0.59% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 386,498 | $12,174,687 | 0.54% | |
| EXEL |
Exelixis, Inc.
Healthcare
|
NEW | 251,500 | $10,786,835 | 0.48% | |
| ANAB |
Anaptysbio, Inc
Healthcare
|
Reduced | 248,253 | $9,178,732 | 0.41% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
NEW | 679,578 | $8,610,253 | 0.38% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
NEW | 395,081 | $8,265,094 | 0.37% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
NEW | 204,015 | $7,813,774 | 0.35% | |
| REPL |
Replimune Group, Inc.
Healthcare
|
NEW | 1,015,400 | $7,767,810 | 0.34% | |
| AXGN |
Axogen, Inc.
Healthcare
|
NEW | 210,665 | $6,979,331 | 0.31% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
NEW | 344,166 | $6,504,737 | 0.29% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
NEW | 91,791 | $6,049,944 | 0.27% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Reduced | 78,320 | $5,007,780 | 0.22% | |
| MANE |
Veradermics, Inc
Healthcare
|
NEW | 73,315 | $4,629,842 | 0.20% |